Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +1.06% | +2.41% |
2020 | Mark Corrigan Departs as CEO from Correvio Pharma Corp | CI |
2020 | Justin Renz, CFO Departs from Correvio Pharma Corp | CI |
Sales 2018 | 28.67M 2.26B | Sales 2019 | 32.63M 2.57B | Capitalization | 27.28M 2.15B |
---|---|---|---|---|---|
Net income 2018 | -16M -1.26B | Net income 2019 | -35M -2.76B | EV / Sales 2018 | 5.13 x |
Net Debt 2018 | 25.92M 2.04B | Net Debt 2019 | 33.9M 2.67B | EV / Sales 2019 | 1.87 x |
P/E ratio 2018 |
-7.1
x | P/E ratio 2019 |
-0.68
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 86.23% |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Ramkumar
BRD | Director/Board Member | - | - |
Andreas Stickler
BRD | Director/Board Member | 53 | - |
Robert Ford
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+15.09% | 74.45B | |
+11.35% | 9.18B | |
+54.35% | 5.03B | |
-12.85% | 5.02B | |
+1.60% | 3.82B | |
-20.85% | 2.41B | |
+16.88% | 2.39B | |
-29.25% | 2.27B | |
+24.62% | 2.26B |
- Stock Market
- Equities
- CORV Stock
- CORV Stock